Phillip M. Satow is currently Chairman of the Board of Directors of JDS Therapeutics, an innovative health care company and parent company of Nutrition 21, LLC, and a leader in the nutritional supplement industry.
Mr. Satow is the former president of Forest Pharmaceuticals, Inc., and former executive vice president and member of the Board of Directors of Forest Laboratories, Inc., its parent company. In addition, to the Forest Laboratories board, on which he served on from 1999-2005, Mr. Satow formerly was a member of the Board of Directors of Eyetech Pharmaceuticals, Inc., Noven Pharmaceuticals, Inc., and Crucell, Inc., a Dutch publicly traded biotech company. He was co-founder, chairman and CEO of JDS Pharmaceuticals LLC, which developed and marketed branded pharmaceutical products before it was acquired in 2007.
He is a past chair of the Columbia College Fund, a past president of the Columbia College Alumni Association and a recipient of the John Jay Award for distinguished professional achievement. Mr. Satow was the recipient of the Alexander Hamilton Award in 2015, the highest honor paid to a member of the Columbia College community,
In 2000, Mr. Satow and his wife, Donna GS’65, co-founded The Jed Foundation, a public charity committed to reducing the young adult suicide rate and improving the mental health support provided to students by universities nationwide. The Foundation is collaborating on mental health programming with hundreds of universities that enroll several million students. Mr. Satow is board chairman.
Mr. Satow’s son, Michael, is a member of the Class of 1988 and a current member of the Board of Visitors and his daughter, Julie, is a member of the Class of 1996.